U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Drugs
  3. News & Events for Human Drugs
  4. 16th Annual Sentinel Initiative Public Workshop - 11/07/2024
  1. News & Events for Human Drugs

Public | Mixed

Event Title
16th Annual Sentinel Initiative Public Workshop
November 7, 2024


Date:
November 7, 2024
Time:
9:00 AM - 4:15 PM ET
Location:
Event Location
National Press Club
Holeman Lounge

529 14th Street NW
Washington, DC 20045
United States



Registration


Summary

The U.S. Food and Drug Administration, under a cooperative agreement with the Duke-Margolis Institute for Health Policy, is hosting the 16th Annual Sentinel Initiative Public Workshop on November 7, 2024, at the National Press Club in Washington, D.C.  

Register to attend this workshop and join the discussion on the Sentinel Initiative’s recent achievements and developments and engage with the public health community.

Dr. Patrizia Cavazzoni, director of the Center for Drug Evaluation and Research at FDA will provide a keynote address. Other FDA leaders will provide remarks on major developments and milestones including: 

  • Important regulatory outcomes,  
  • Methodology improvements, 
  • How the FDA leverages the Biologics Effectiveness and Safety (BEST) System to address safety and effectiveness of biologics, and   
  • Accomplishments and updates since the 15th Annual Sentinel Initiative Public Workshop

For more information on the annual Sentinel Initiative workshop please visit the FDA’s Sentinel Initiative News and Events page or Duke Margolis annual public workshop event page.

Back to Top